Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 319,336,192
  • Shares Outstanding, K 1,770,647
  • Annual Sales, $ 54,318 M
  • Annual Income, $ 4,863 M
  • 60-Month Beta 0.58
  • Price/Sales 5.84
  • Price/Cash Flow 11.29
  • Price/Book 30.91
Trade ABBV with:

Options Overview Details

View History
  • Implied Volatility 20.76% ( -0.39%)
  • Historical Volatility 14.01%
  • IV Percentile 66%
  • IV Rank 40.68%
  • IV High 28.31% on 10/19/23
  • IV Low 15.58% on 09/01/23
  • Put/Call Vol Ratio 0.51
  • Today's Volume 2,523
  • Volume Avg (30-Day) 12,758
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 310,664
  • Open Int (30-Day) 323,449

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 2.33
  • Number of Estimates 4
  • High Estimate 2.40
  • Low Estimate 2.30
  • Prior Year 2.46
  • Growth Rate Est. (year over year) -5.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
175.39 +3.26%
on 02/29/24
182.89 -0.97%
on 03/12/24
+3.11 (+1.75%)
since 02/28/24
3-Month
154.41 +17.29%
on 12/29/23
182.89 -0.97%
on 03/12/24
+26.36 (+17.03%)
since 12/28/23
52-Week
130.96 +38.29%
on 06/28/23
182.89 -0.97%
on 03/12/24
+22.86 (+14.45%)
since 03/28/23

Most Recent Stories

More News
3 Passive Income Stocks To Scoop Up Now

These three stocks have earned the title of Dividend Kings by consistently increasing dividends for at least 50 years.

ABT : 113.51 (+0.03%)
$SPX : 5,251.16 (+0.05%)
ABBV : 180.98 (+0.35%)
HRL : 35.08 (+0.66%)
3 Highest Yielding Dividend Kings in March 2024

Invest in dividend royalty: not only because they offer a higher-than-average yield, but they are also the highest-rated!

KO : 61.19 (+0.26%)
ABBV : 180.98 (+0.35%)
FRT : 102.84 (+1.28%)
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 158.55 (+0.37%)
CMPS : 8.71 (-8.32%)
MNMD : 9.87 (+3.89%)
ATAI : 1.9300 (+7.82%)
ABBV : 180.98 (+0.35%)
2 Top Dividend Stocks to Buy Hand Over Fist

Every company faces headwinds eventually. The top ones know how to bounce back.

AGN.AX : 0.670 (+13.56%)
ABBV : 180.98 (+0.35%)
GILD : 73.34 (+0.45%)
How Much a $1 Million Portfolio Would Pay in Dividends

See how to construct a $1 million portfolio.

HDV : 109.93 (+0.27%)
DGRO : 57.97 (+0.16%)
VZ : 41.75 (+0.51%)
KO : 61.19 (+0.26%)
O : 54.14 (+1.18%)
ABBV : 180.98 (+0.35%)
VICI : 29.84 (+0.30%)
SBUX : 91.69 (+0.21%)
SCHW : 71.90 (-0.66%)
SCHD : 80.49 (+0.32%)
3 Pharmaceutical Stocks to Buy Hand Over Fist in March

There are some great companies at attractive prices in the lucrative pharmaceutical space.

PFE : 27.85 (+0.25%)
ABBV : 180.98 (+0.35%)
DNA : 1.1750 (+6.82%)
The AI Race Gets Litigious

We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.

AXON : 314.98 (-0.21%)
AAPL : 170.73 (-1.49%)
GILD : 73.34 (+0.45%)
AMGN : 285.94 (-0.13%)
EBAY : 52.53 (+1.17%)
PANW : 284.26 (+0.71%)
OKTA : 105.24 (+0.30%)
CRM : 301.24 (-0.05%)
ABBV : 180.98 (+0.35%)
Have $2,500? 2 Superior Growth Stocks to Buy in 2024

These businesses can pack a punch in your portfolio over the long run.

ABBV : 180.98 (+0.35%)
MRK : 131.57 (-0.14%)
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END

OCEA : 3.93 (-3.20%)
ONCY : 1.0300 (-0.49%)
ONC.TO : 1.40 (+1.45%)
LVTX : 3.75 (-4.09%)
MRK : 131.57 (-0.14%)
ABBV : 180.98 (+0.35%)
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments

ONCY : 1.0300 (-0.49%)
ONC.TO : 1.40 (+1.45%)
LVTX : 3.75 (-4.09%)
MRK : 131.57 (-0.14%)
ABBV : 180.98 (+0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi...

See More

Key Turning Points

3rd Resistance Point 182.79
2nd Resistance Point 181.68
1st Resistance Point 181.02
Last Price 180.94
1st Support Level 179.25
2nd Support Level 178.14
3rd Support Level 177.48

See More

52-Week High 182.89
Last Price 180.94
Fibonacci 61.8% 163.05
Fibonacci 50% 156.93
Fibonacci 38.2% 150.80
52-Week Low 130.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar